The State of Alabama’s next Medicaid fraud trial will occur on December 7, 2009 against Defendants Watson Laboratories, Watson Pharma, Inc. and Watson Pharmaceuticals, Inc. The Watson Defendants were previously consolidated with Defendants Abbott Laboratories, Forest Laboratories and Forest Pharmaceuticals, Inc., but these Defendants recently settled all of the claims that the State of Alabama alleged against them as part of the recently-announced $89 million settlement this past June. The Watson Defendants were the only Defendants remaining from that consolidation after the settlement was concluded. Again, that trial will begin on December 7, 2009.
After the Watson Defendants’ trial, the State’s next trial will take place on January 25, 2010 against Defendants Mylan Laboratories, Mylan Pharmaceuticals, Inc., and UDL Laboratories, Inc. These generic drug companies will face their first- ever Medicaid fraud trial before a Montgomery County jury in January. This case was originally set for trial on September 22, 2009, but due to scheduling conflicts by the Mylan lawyers, the case had to be rescheduled for January, 2010.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.